A. Walker

1.4k total citations
10 papers, 237 citations indexed

About

A. Walker is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A. Walker has authored 10 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in A. Walker's work include Multiple Sclerosis Research Studies (2 papers), Plant Virus Research Studies (2 papers) and Polyomavirus and related diseases (2 papers). A. Walker is often cited by papers focused on Multiple Sclerosis Research Studies (2 papers), Plant Virus Research Studies (2 papers) and Polyomavirus and related diseases (2 papers). A. Walker collaborates with scholars based in United States, United Kingdom and Canada. A. Walker's co-authors include Gordon Murray, David Young, Keith Millar, W D George, Sheila Stallard, Arnie Purushotham, Julie Doughty, Jane Walker, Richard G. Roberts and C. Hibberd and has published in prestigious journals such as Neurology, PLoS Medicine and Psychological Medicine.

In The Last Decade

A. Walker

8 papers receiving 223 citations

Peers

Countries citing papers authored by A. Walker

Since Specialization

Citations

This map shows the geographic impact of A. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Walker more than expected).

Fields of papers citing papers by A. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Walker. The network helps show where A. Walker may publish in the future.

Co-authorship network of co-authors of A. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of A. Walker. A scholar is included among the top collaborators of A. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Walker. A. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Prognostic significance of CD8+ T cell Spatial Biomarkers in ER+ and ER− breast cancer: A retrospective cohort study 2025 ·PLoS Medicine ·A. Walker, Xiaohua Gao, (unknown), Gabriela De la Cruz, (unknown), Charles M. Perou, Joel Saltz, J. S. Marron, Katherine A. Hoadley, Melissa A. Troester	0
2	Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo‐controlled trials in adults with severe constipation 2023 ·Neurogastroenterology & Motility ·Brooks D. Cash, Amol Sharma, A. Walker, (unknown), Lin Chang	3
3	Rotator cuff outcomes and mental health indices: Correlation or causation? 2022 ·Shoulder & Elbow ·Marlis T. Sabo, A. Walker, (unknown), Kevin A. Hildebrand	1
4	The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada 2013 ·Value in Health ·Wei‐Wen Su, A. Walker, Sujata P. Sarda, M. Feldman, (unknown), Baris Deniz	3
5	A benefit–risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy 2013 ·Current Medical Research and Opinion ·A. Walker, Crystal Watson, (unknown), Baris Deniz, Ryan Arnold, David O. Bates	5
6	PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in Sweden 2012 ·Value in Health ·(unknown), Baris Deniz, A. Walker, R. Arnold, David O. Bates	0
7	PND1 A Risk-Benefit Analysis of Natalizumab Across PML Risk Sub-Groups in Patients With Relapsing-Remitting Multiple Sclerosis 2012 ·Value in Health ·A. Walker, Baris Deniz, (unknown), R. Arnold, David O. Bates	1
8	Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome 2009 ·Psychological Medicine ·Michael Sharpe, Jon Stone, C. Hibberd, C Warlow, Roderick Duncan, R. Coleman, Richard G. Roberts, Roger E. Cull, Anthony J. Pelosi, Jonathan Cavanagh, K. Matthews, Rainer Goldbeck, Roger Smyth, A. Walker, Jane Walker, Aoife MacMahon, Gordon Murray, Alan Carson	81
9	Randomized clinical trial of no wound drains and early discharge in the treatment of women with breast cancer 2002 ·British journal of surgery ·Arnie Purushotham, (unknown), David Young, W D George, Sheila Stallard, Julie Doughty, (unknown), (unknown), A. Walker, Keith Millar, Gordon Murray	103
10	Surgical therapy for tremor in multiple sclerosis 2001 ·Neurology ·Joseph Y. Matsumoto, Duane A. Morrow, Kenton R. Kaufman, D.H. Davis, J. Eric Ahlskog, A. Walker, (unknown), John H. Noseworthy, Moses Rodriguez	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact